Kensuke Toyama

2.3k total citations · 1 hit paper
57 papers, 1.7k citations indexed

About

Kensuke Toyama is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Kensuke Toyama has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 17 papers in Molecular Biology and 14 papers in Neurology. Recurrent topics in Kensuke Toyama's work include Neurological Disease Mechanisms and Treatments (10 papers), Renin-Angiotensin System Studies (8 papers) and MicroRNA in disease regulation (7 papers). Kensuke Toyama is often cited by papers focused on Neurological Disease Mechanisms and Treatments (10 papers), Renin-Angiotensin System Studies (8 papers) and MicroRNA in disease regulation (7 papers). Kensuke Toyama collaborates with scholars based in Japan, United States and Germany. Kensuke Toyama's co-authors include Shokei Kim‐Mitsuyama, Nobutaka Koibuchi, Daisuke Sueta, Hisao Ogawa, Ken Uekawa, Yu Hasegawa, Takashi Nakagawa, Mingjie Ma, Keiichiro Kataoka and Bo-Wen Lin and has published in prestigious journals such as Circulation, PLoS ONE and Scientific Reports.

In The Last Decade

Kensuke Toyama

56 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

2014 336 citations Bo-Wen Lin, Nobutaka Koibuchi et al. Cardiovascular Diabetology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kensuke Toyama Japan	25	461	453	448	383	307	57	1.7k
Paulo W. Pires United States	20	329 0.7×	371 0.8×	313 0.7×	327 0.9×	353 1.1×	46	1.6k
Keiichiro Kataoka Japan	28	665 1.4×	689 1.5×	375 0.8×	284 0.7×	432 1.4×	45	2.1k
Ken Uekawa Japan	21	257 0.6×	370 0.8×	402 0.9×	491 1.3×	337 1.1×	46	1.5k
Takahiko Kawamura Japan	20	359 0.8×	398 0.9×	472 1.1×	247 0.6×	475 1.5×	37	2.0k
Kana Tsukuda Japan	28	869 1.9×	730 1.6×	477 1.1×	343 0.9×	437 1.4×	60	2.0k
Sasiwan Kerdphoo Thailand	23	290 0.6×	736 1.6×	300 0.7×	161 0.4×	455 1.5×	72	1.6k
Norio Hotta Japan	27	402 0.9×	459 1.0×	427 1.0×	129 0.3×	637 2.1×	122	2.3k
Yoshiko Tokutomi Japan	21	488 1.1×	487 1.1×	273 0.6×	123 0.3×	392 1.3×	34	1.6k
Thidarat Jaiwongkam Thailand	24	215 0.5×	592 1.3×	329 0.7×	146 0.4×	368 1.2×	58	1.4k
Christoph Köhler Germany	16	790 1.7×	540 1.2×	268 0.6×	141 0.4×	737 2.4×	30	2.2k

Countries citing papers authored by Kensuke Toyama

Since Specialization

Citations

This map shows the geographic impact of Kensuke Toyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Toyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Toyama more than expected).

Fields of papers citing papers by Kensuke Toyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensuke Toyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Toyama. The network helps show where Kensuke Toyama may publish in the future.

Co-authorship network of co-authors of Kensuke Toyama

This figure shows the co-authorship network connecting the top 25 collaborators of Kensuke Toyama. A scholar is included among the top collaborators of Kensuke Toyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensuke Toyama. Kensuke Toyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Toyama, Kensuke, et al.. (2024). Lack of ATP2B1 in CD4+ T Cells Causes Colitis. Inflammatory Bowel Diseases. 30(10). 1852–1864.

Yoshida, Daisuke, et al.. (2024). Triglyceride-Glucose Index Associated with Future Renal Function Decline in the General Population. Journal of General Internal Medicine. 39(16). 3225–3233. 10 indexed citations

Mukohda, Masashi, Takanori Yano, Toshiyasu Matsui, et al.. (2023). Treatment with Ligilactobacillus murinus lowers blood pressure and intestinal permeability in spontaneously hypertensive rats. Scientific Reports. 13(1). 15197–15197. 30 indexed citations

Toyama, Kensuke, Joshua M. Spin, Alicia Deng, et al.. (2022). Role of MicroRNAs in acceleration of vascular endothelial senescence. Biochemistry and Biophysics Reports. 30. 101281–101281. 4 indexed citations

Abe, Yasunori, Kensuke Toyama, Akio Shinohara, et al.. (2022). Message to researchers: the characteristic absence of a posterior communicating artery is easily lost in the gerbil. Anatomical Science International. 98(3). 426–433. 1 indexed citations

Liu, Shuang, et al.. (2019). Histamine uptake mediated by plasma membrane monoamine transporter and organic cation transporters in rat mast cell lines. European Journal of Pharmacology. 849. 75–83. 7 indexed citations

Toyama, Kensuke, Joshua M. Spin, Yasunori Abe, et al.. (2019). Controlled isoflurane anesthesia exposure is required for reliable behavioral testing in murine surgical models. Journal of Pharmacological Sciences. 140(1). 106–108. 6 indexed citations

Toyama, Kensuke, Joshua M. Spin, Masaki Mogi, & Philip S. Tsao. (2019). Therapeutic perspective on vascular cognitive impairment. Pharmacological Research. 146. 104266–104266. 27 indexed citations

Kurokawa, Hirofumi, Seigo Sugiyama, Toshimitsu Nozaki, et al.. (2015). Telmisartan enhances mitochondrial activity and alters cellular functions in human coronary artery endothelial cells via AMP-activated protein kinase pathway. Atherosclerosis. 239(2). 375–385. 19 indexed citations

10.

Toyama, Kensuke, Nobutaka Koibuchi, Yu Hasegawa, et al.. (2015). ASK1 is involved in cognitive impairment caused by long-term high-fat diet feeding in mice. Scientific Reports. 5(1). 10844–10844. 20 indexed citations

11.

Hasegawa, Yu, Nobutaka Koibuchi, Kensuke Toyama, et al.. (2015). DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice. Cardiovascular Diabetology. 14(1). 54–54. 67 indexed citations

12.

Toyama, Kensuke, Seigo Sugiyama, Hideki Oka, et al.. (2014). Statins combined with exercise are associated with the increased renal function mediated by high-molecular-weight adiponectin in coronary artery disease patients. Journal of Cardiology. 64(2). 91–97. 5 indexed citations

13.

Koibuchi, Nobutaka, Yu Hasegawa, Tetsuji Katayama, et al.. (2014). DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure. Cardiovascular Diabetology. 13(1). 157–157. 51 indexed citations

14.

Lin, Bo-Wen, Nobutaka Koibuchi, Yu Hasegawa, et al.. (2014). Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice. Cardiovascular Diabetology. 13(1). 148–148. 336 indexed citations breakdown →

15.

Sueta, Daisuke, Nobutaka Koibuchi, Yu Hasegawa, et al.. (2014). Telmisartan Exerts Sustained Blood Pressure Control and Reduces Blood Pressure Variability in Metabolic Syndrome by Inhibiting Sympathetic Activity. American Journal of Hypertension. 27(12). 1464–1471. 23 indexed citations

16.

Toyama, Kensuke, Seigo Sugiyama, Hideki Oka, et al.. (2012). Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease. PLoS ONE. 7(7). e41369–e41369. 29 indexed citations

17.

Toyama, Kensuke, Hiroshige Yamabe, Takashi Uemura, et al.. (2012). Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2′-deoxyguanosine and biopyrrin in atrial fibrillation: Effect of sinus rhythm restoration. International Journal of Cardiology. 168(1). 80–85. 22 indexed citations

18.

Dong, Yi‐Fei, Keiichiro Kataoka, Yoshiko Tokutomi, et al.. (2011). Beneficial Effects of Combination of Valsartan and Amlodipine on Salt-Induced Brain Injury in Hypertensive Rats. Journal of Pharmacology and Experimental Therapeutics. 339(2). 358–366. 24 indexed citations

19.

Toyama, Kensuke, Taishi Nakamura, Keiichiro Kataoka, et al.. (2011). Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity. Biochemical and Biophysical Research Communications. 410(3). 508–513. 33 indexed citations

20.

Tokutomi, Yoshiko, Keiichiro Kataoka, Eiichiro Yamamoto, et al.. (2011). Vascular responses to 8‐nitro‐cyclic GMP in non‐diabetic and diabetic mice. British Journal of Pharmacology. 162(8). 1884–1893. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact